← Back to Search

Behavioral Intervention

Mindfulness Program for Rheumatoid Arthritis (DREAMER Trial)

N/A

Recruiting

Led By Sarah Patterson, MD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Physician-confirmed diagnosis of rheumatoid arthritis (RA)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

DREAMER Trial Summary

This trial will test a mindfulness program in individuals with rheumatoid arthritis (RA). The goals are to assess patient satisfaction, identify barriers to participation, and understand how mindfulness impacts RA symptoms. Participants will

Who is the study for?

This trial is for individuals with an active rheumatoid arthritis diagnosis who can access the internet via a computer or mobile device. It's not suitable for those in RA remission, already practicing mindfulness regularly, unable to commit to an 8-week course, or have completed a similar MBSR course before.Check my eligibility

What is being tested?

The study tests a mindfulness program against standard care in people with rheumatoid arthritis. Participants will fill out questionnaires, undergo exams and blood draws, and may join an online mindfulness course or focus group to evaluate satisfaction and barriers.See study design

What are the potential side effects?

Since this trial involves a non-medical intervention (mindfulness), typical drug side effects are not expected. However, participants might experience emotional discomfort or increased awareness of stress during the practice.

DREAMER Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My doctor has diagnosed me with rheumatoid arthritis.

DREAMER Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patient Satisfaction as Assessed by CSQ-8, Adapted for DREAMER Study

Secondary outcome measures

MBSR Course Attendance (Intervention Adherence)

Percent of Study Completers (Study Retention)

Other outcome measures

Brief Resilience Scale

Clinical Disease Activity Index (CDAI)

Disease Activity Score in 28 Joints (DAS-28)

+5 more

DREAMER Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Mindfulness ProgramExperimental Treatment1 Intervention

Individuals in the mindfulness group will complete an 8-week mindfulness course that has been adapted for individuals with rheumatic diseases (MBSR-RD).

Group II: Treatment as Usual (TAU)Active Control1 Intervention

Individuals in the TAU group will continue engaging in routine care and be asked to refrain from participating in mindfulness programs during the trial.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Mindfulness Program

2016

N/A

~110

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Center for Complementary and Integrative Health (NCCIH)NIH

833 Previous Clinical Trials

669,413 Total Patients Enrolled

8 Trials studying Rheumatoid Arthritis

590 Patients Enrolled for Rheumatoid Arthritis

University of California, San FranciscoLead Sponsor

2,506 Previous Clinical Trials

15,238,515 Total Patients Enrolled

5 Trials studying Rheumatoid Arthritis

426 Patients Enrolled for Rheumatoid Arthritis

Sarah Patterson, MDPrincipal InvestigatorUniversity of California, San Francisco

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any ongoing efforts to enlist patients for this research study?

"Indeed, the data available on clinicaltrials.gov affirms that this medical trial is actively pursuing eligible participants. First appearing online on January 26th, 2024 and most recently modified on February 16th, 2024, the research seeks to enroll a total of 40 individuals from one designated site."

Answered by AI

How many individuals are participating in the entirety of this medical study?

"Indeed, information on clinicaltrials.gov confirms that this investigation is actively seeking eligible individuals. The trial was first listed on January 26th, 2024 and the latest update was made on February 16th of the same year. This study aims to enroll a total of 40 participants across one designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Defining Stress REsilience And Mindfulness Effects in Rheumatoid Arthritis

2024. "Defining Stress REsilience And Mindfulness Effects in Rheumatoid Arthritis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06276387.

All > Rheumatoid Arthritis > Sacramento